Aude Braye

Aude Braye

Auto-generated profile, based on publicly available information

Aude Braye

Department of Reproduction, Genetics and Regenerative Medicine (RGRG), Biology of the Testis (BITE) Vrije Universiteit Brussel (VUB), Laarbeeklaan Brussels Belgium

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Fertility and Sterility
Verified
Journal Article
Closed access
YBYoni Baert
Yoni Baert
ABAude Braye
Aude Braye
Robin StruijkRobin Struijk
Robin Struijk
APAns van Pelt
Ans van Pelt
EGEllen Goossens
Ellen Goossens

1 January 2019 in Clinical Medicine Insights: Reproductive Health
Verified
Journal Article
Open access
PDF file
ABAude Braye
Aude Braye
HTHerman Tournaye
Herman Tournaye
EGEllen Goossens
Ellen Goossens
Young boys undergoing gonadotoxic treatments are at high risk of spermatogonial stem cell (SSC) loss and fertility problems later in life. Stem cell loss can also occur in specific genetic conditions, eg, Klinefelter syndrome (KS). Before puberty, these boys do not yet produce sperm. Hence, they cannot benefit from sperm banking. An emerging alternative is the freezing of testicular tissue aiming to preserve the SSCs for eventual autologous transplantation or in vitro maturation at adult age. Many fertility preservation programmes include cryopreservation of immature testicular tissue, although the restoration procedures are still under development. Until the end of 2018, the Universitair Ziekenhuis Brussel has frozen testicular tissues of 112 patients between 8 months and 18 years of age. Testicular tissue was removed in view of gonadotoxic cancer treatment (35%), gonadotoxic conditioning therapy for bone marrow transplantation (35%) or in boys diagnosed with KS (30%). So far, none of these boys had their testicular tissue transplanted back. This article summarizes our experience with cryopreservation of immature testicular tissue over the past 16 years (2002-2018) and describes the key issues for setting up a cryopreservation programme for immature testicular tissue as a means to safeguard the future fertility of boys at high risk of SSC loss.

7 May 2023 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
ABAude Braye
Aude Braye
EDEmily Delgouffe
Emily Delgouffe
JBJutte van der Werff Ten Bosch
Jutte van der Werff Ten Bosch
IGInge Gies
Inge Gies
AFAlina Ferster
Alina Ferster
EGEllen Goossens
Ellen Goossens
Background: Experimental fertility preservation programs have been started to safeguard the future fertility of prepubertal and pubertal males requiring high‐risk gonadotoxic treatment protocols. However, long‐term follow‐up studies evaluating the effects on their gonadal development and function related to the testicular biopsy procedure are rather limited.Design: This two‐center follow‐up study (between 2002 and 2020) evaluated the gonadal development and function of a cohort of 59 prepubertal and pubertal males who have been offered immature testicular tissue banking (TTB) prior to conventional high‐risk chemo‐ and/or radiotherapy (HR‐C/R) or conditioning therapy before hematopoietic stem cell transplantation (CT‐HSCT). The aim is to investigate the long‐term impact of the testicular biopsy procedure and the high‐risk gonadotoxic treatment. Testicular growth and the reproductive hormones luteinizing hormone (LH), follicle‐stimulating hormone (FSH), testosterone (T), and inhibin B (INHB) were analyzed after treatment completion, and compared between males accepting TTB and those refusing TTB (control) as well as between HR‐C/R and CT‐HSCT treatment protocols.Results: Of the 59 prepubertal and pubertal males included, 25 were treated by HR‐C/R and 34 required CT‐HSCT. TTB was accepted for 39 males and refused for 20 males. Most patients were prepubertal at diagnosis (85%), at TTB (79%), and at treatment completion (76%), and pubertal or postpubertal at their last follow‐up visit (66%). After 5.0 (1.0–13.0) years post treatment, most patients show normal testicular volumes (83%) and normal LH (89%), FSH (87%), T (87%), and INHB (79%) serum levels. The testicular biopsy procedure did not have an effect on testicular growth, LH, FSH, T, and INHB. Significantly more small postpubertal testicular volumes (p = .0278) and low INHB serum levels (p = .0130) were recorded after CT‐HSCT, especially after myeloablative conditioning.Conclusion: The clinical follow‐up data demonstrate no effect related to the biopsy procedure, but a substantial risk for impaired gonadal development after high‐risk gonadotoxic treatment, in particular myeloablative CT‐HSCT. Longer follow‐up studies with a larger study population are needed to confirm these preliminary findings.

3 February 2022 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
ABAude Braye
Aude Braye
SBSusanne Böhler
Susanne Böhler
VVVeerle Vloeberghs
Veerle Vloeberghs
VBVeerle De Boe
Veerle De Boe
JSJean De Schepper
Jean De Schepper
EGEllen Goossens
Ellen Goossens